Arthronica Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Liquidation

  • Investors
  • 1

Arthronica General Information

Description

Developer of patient monitoring and rehabilitation system designed for patients and practitioners to cure Arthritis. The company's system leverages artificial intelligence for skeletal tracking, force-sensing vision, and 3D CAD modeling to measure swelling, thereby enabling medical practitioners to measure the disease progression of their patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 16 Great Queen Street
  • Covent Garden
  • London WC2B 5AH
  • England, United Kingdom
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
LOHAS & Wellness, SaaS, Artificial Intelligence & Machine Learning
Corporate Office
  • 16 Great Queen Street
  • Covent Garden
  • London WC2B 5AH
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arthronica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation 13-Aug-2021 Completed Bankruptcy: Liquidation
6. Accelerator/Incubator Completed Generating Revenue
5. Seed Round 06-Jul-2020 Completed Generating Revenue
4. Grant 27-Sep-2019 Completed Generating Revenue
3. Accelerator/Incubator 26-Sep-2019 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
1. University Spin-Out 01-Jan-2018 Completed Startup
To view Arthronica’s complete valuation and funding history, request access »

Arthronica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
Preference
Ordinary 2,070 $0.012495 $248.07 $248.07 1x $248.07 15.25%
To view Arthronica’s complete cap table history, request access »

Arthronica Patents

Arthronica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202016360-D0 Three-dimensional kinematics estimation and tracking Inactive 15-Oct-2020

Arthronica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arthronica Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech SuperConnector Accelerator/Incubator Minority
To view Arthronica’s complete investors history, request access »

Arthronica FAQs

  • When was Arthronica founded?

    Arthronica was founded in 2018.

  • Who is the founder of Arthronica?

    Letizia Gionfrida, Nicholas Hughes, and Suruchi Kothari are the founders of Arthronica.

  • Where is Arthronica headquartered?

    Arthronica is headquartered in London, United Kingdom.

  • What is the size of Arthronica?

    Arthronica has 12 total employees.

  • What industry is Arthronica in?

    Arthronica’s primary industry is Monitoring Equipment.

  • Is Arthronica a private or public company?

    Arthronica is a Private company.

  • What is Arthronica’s current revenue?

    The current revenue for Arthronica is .

  • How much funding has Arthronica raised over time?

    Arthronica has raised $755K.

  • Who are Arthronica’s investors?

    MedTech SuperConnector has invested in Arthronica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »